Automatic hematology analyzer DxH 900
portable

Automatic hematology analyzer - DxH 900 - Beckman Coulter - portable
Automatic hematology analyzer - DxH 900 - Beckman Coulter - portable
Automatic hematology analyzer - DxH 900 - Beckman Coulter - portable - image - 2
Automatic hematology analyzer - DxH 900 - Beckman Coulter - portable - image - 3
Automatic hematology analyzer - DxH 900 - Beckman Coulter - portable - image - 4
Automatic hematology analyzer - DxH 900 - Beckman Coulter - portable - image - 5
Automatic hematology analyzer - DxH 900 - Beckman Coulter - portable - image - 6
Add to favorites
Compare this product
 

Characteristics

Operation
automatic
Configuration
portable
Throughput

100 p/h

Sample volume

0.165 ml
(0.00558 US fl oz)

Weight

254 kg
(560 lb)

Width

75.6 cm
(29.8 in)

Height

174 cm
(68.5 in)

Description

The DxH 900 Hematology Analyzer delivers accurate, first-analysis results through proprietary VCS technology. With fewer slide reviews and high system reliability for maximum uptime, this powerful analyzer streamlines processes to maximize laboratory staff time. The analyzer is compatible with clinical informatics and automation solutions to form scalable, customized solutions. Achieve superb RBC, PLT and WBC differentials through near native-state cellular characterization Deliver reliable, reportable WBC differential results on the first run, through VCS technology, DataFusion and the enhanced Coulter Principle. These core technologies provide high-resolution characterization without altering cell morphology, providing excellent hematological test results Support critical clinical decisions through advanced PLT analysis. The enhanced Coulter Principle provides a reportable MPV—even for thrombocytopenic patients—while DataFusion leverages inter-module intelligence to enable improved flagging and identification of interferences Assess anemia with accuracy by maintaining near native-state cellular characterization throughout the RBC maturation cycle Facilitate confident slide interpretations through intelligent slide-making. Hemasphere technology analyzes blood viscosity to optimize smearing, and DxH Slidemaker Stainer II ensures consistent slide quality Ensure predictable costs and >30% faster break-even point Experience low cost of ownership through a 93% first-pass yield and predictable reagent consumption Reduce manual interventions with automated maintenance procedures and less reagent turnover to maximize walkaway time

VIDEO

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.